Polomar Health Services, Inc. (PMHS) — SEC Financial Statements & Analysis

Polomar Health Services, Inc. (PMHS) is a pharmaceutical preparations company, incorporated in NV. Polomar Health Services, Inc. trades on OTC as: PMHS. Polomar Health Services, Inc. (PMHS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Polomar Health Services, Inc. carries a market cap of $3.31M, a P/E ratio of -0.35x, a P/B ratio of -3.13x, a P/S ratio of 1.04x, an enterprise value of $3.13M, and an EV/EBITDA multiple of -36.43x. On profitability, it posts a gross margin of 61.14%, an operating margin of -295.04%, a net margin of -298.31%, a Return on Equity (ROE) of -257.88%, a Return on Assets (ROA) of -184.70%, and a Return on Invested Capital (ROIC) of -26.92%. Per share, it reports EPS of $-0.34, diluted EPS of $-0.34, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 7688.77% year-over-year, net income growth of 361.07% year-over-year, and EPS growth of 354.66% year-over-year. On the balance sheet, it maintains a current ratio of 0.27x, a quick ratio of 0.15x, working capital of $-1.29M, a debt-to-equity ratio of -1.41x, a debt ratio of 3.41, an interest coverage ratio of -90.30x, free cash flow of $-6.96K (TTM), and net debt of $-178.87K. Figures sourced from SEC EDGAR.

Market Cap

$3.31M

P/E TTM

-0.35x

EPS TTM

$-0.34

P/B TTM

-3.13x

ROE TTM

-257.88%

ROA TTM

-184.70%

Debt To Equity

-1.41x

Free Cash Flow TTM

$-6.96K

Net Revenue TTM Growth 1Y

7688.77%

Data as of 2026-06-30 · Source: SEC EDGAR